Skip to main content

Gastric Outlet Obstruction

0
Pipeline Programs
5
Companies
6
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

5 companies ranked by most advanced pipeline stage

Boston Scientific
Boston ScientificCA - Valencia
3 programs
AXIOSN/A1 trial
Hot AXIOS system used for EPASSN/A1 trial
Lumen-apposing metal stentN/A1 trial
Active Trials
NCT06174805Suspended67Est. Sep 2027
NCT05644951Completed51Est. Aug 2025
NCT03259763Completed112Est. Jan 2026
Verona Pharma
Verona PharmaUK - London
1 program
EUS-guided gastroenterostomyN/A1 trial
Active Trials
NCT05605327Unknown120Est. Oct 2024
Eppendorf
EppendorfGermany - Hamburg
1 program
EUS-guided gastrojejunostomyN/A1 trial
Active Trials
NCT05548114Active Not Recruiting74Est. Dec 2025
GT Biopharma
GT BiopharmaSAN FRANCISCO, CA
1 program
Magnet SystemN/A
GT Metabolic Solutions
GT Metabolic SolutionsMN - St. Michael
1 program
Magnet SystemN/A1 trial
Active Trials
NCT07317076Recruiting35Est. Nov 2026

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
GT Metabolic SolutionsMagnet System
Boston ScientificAXIOS
Boston ScientificHot AXIOS system used for EPASS
Verona PharmaEUS-guided gastroenterostomy
EppendorfEUS-guided gastrojejunostomy
Boston ScientificLumen-apposing metal stent

Clinical Trials (6)

Total enrollment: 459 patients across 6 trials

NCT07317076GT Metabolic SolutionsMagnet System

GT Metabolic Magnet System in Adults With Gastrointestinal Disorders

Start: Dec 2025Est. completion: Nov 202635 patients
N/ARecruiting
NCT06174805Boston ScientificAXIOS

AXIOS™ Gastroenterostomy for Gastric Outlet Obstruction IDE

Start: Feb 2025Est. completion: Sep 202767 patients
N/ASuspended
NCT05644951Boston ScientificHot AXIOS system used for EPASS

Clinical Trial of EPASS With Hot AXIOS System

Start: Dec 2022Est. completion: Aug 202551 patients
N/ACompleted
NCT05605327Verona PharmaEUS-guided gastroenterostomy

EUS-guided Versus Laparoscopic Gastrojejunostomy for Malignant Gastric Outlet Obstruction

Start: Nov 2022Est. completion: Oct 2024120 patients
N/AUnknown
NCT05548114EppendorfEUS-guided gastrojejunostomy

Randomized Trial of EUS-guided Gastrojejunostomy and Surgical Gastrojejunostomy in Gastric Outlet Obstruction

Start: Sep 2022Est. completion: Dec 202574 patients
N/AActive Not Recruiting
NCT03259763Boston ScientificLumen-apposing metal stent

EUS-GE vs ES for Palliation of Gastric Outlet Obstruction

Start: Oct 2020Est. completion: Jan 2026112 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 459 patients
5 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.